Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
As the US and Chinese President Donald Trump and President Xi Xin Phase, President Donald Trump and President Donald Trump and, in turn, have a disproportionate effect on the health of Americans.
The United States imports 75 percent of the main drugs. Trump management started the investigation Active ingredients needed to say medication imports and active ingredients, a lack of absence in the United States. Sector tariffs threatened – this can now change from 7.5 percent to 100 percent in China.
Although pharmaceuticals are exempt from Trump to date, this will last, especially with the potential sector protection in the pipeline.
In the immediate period, there are some insulation between growing prices, and what consumers will pay when they go to take their medications at the local pharmacy.
Unlike other goods, the pharmaceutical prices for consumers are not subject to market fluctuations at the same time. Throughout the pharmaceutical industry, complex supply is a decline between the chain of supply, tariffs and the effects of patients.
At the same time, there are stockings in almost every step of the supply chain. Wholesalers have pharmaceutical giants and even as a federal government.
“Many of these drugs, especially in pill, especially for a long time,” Bruce Y Lee has long been a health care policy of health and health care in health and health care, Al Casira said.
As soon as possible, pharmaceutical companies and health providers can eat on expenses as they do during the SPOIKE COVID-19 pandemia. Pharmaceutical companies and trade groups give the leadership to admit the leadership to protect the exceptions from the exempt of tariffs.
India provides about half of all common medications used in the United States. However, this is prepared by 60 percent of active drugs (APIs), drug compounds.
One of the largest pharmaceutical giants in the world, the prices of any tariff will increase and the patient will harm the care.
At a joint-stock meeting, the chairman of the Astrazeneca board Michel Demare, “We still believe that we still believe that drugs will have to be exempted from all tariffs, because in the end limits health systems and health care systems. “
Astrazeneca did not respond to Al-Asyn’s desire for the records later.
Eli Lilly and Johnson and Johnson reflected similar concerns. In the last six months, it has invested in multibylion-dollar investment to develop and develop and develop all three companies, in the United States.
But Pharma giants will be able to cost so long. Exchange prices for Pharma giants mean they find other ways to raise stock prices to pay shareholder responsibilities against shareholders. Experts say they can do so by saying that drug prices are higher depending on the drugs. This causes the low stream effect that will lead to higher prices and higher prices and higher prices for Americans who trust these drugs.
“Many pharmacy demand is not flexible. It is not good for the consumer,” Lee said. “When applying something that increases the price, you really can’t change the requirement, as a tariff … and the result is frustrated.”
Socio-economic division
According to a report released last week, the United States relying up to 80 percent of the United States, USA. For general antibiotics, especially addictive are higher than 90 percent.
Because China, China, which has 80 to 85 percent cheap from the brand alternatives, China’s tariffs will damage low-income communities in China.
“If there is a place where you save money, it is the place where the growth is. They are in subtle margins, and they are not in a state of Michael Abrams,” Michael Abrams, in the Global Medicine Consulting Company, “in Michael Abrams.”
The latest analysis of the financial services company, even 25 percent found that a Pharma can compel $ 2,000 for a 24-week supply of cancer tariff.
Tariffs can ensure the land market from the US market, Tom Kraus, the American Health System Assistant Government Assistant President (ASHP) told Al Jazea.
“Tariffs on the drug and their components, a drug that is already out of the US market for a drug can force common medicinal manufacturers, resulting in drug shortages for American patients,” he said.
About 90 percent of medicines identified in US pharmacies are common or biosimilar (similar effects), According to a report From the Association of Medicines that can be perceived in February.
“It will cause many reverberations because it should take one’s tab. This will result in less percentage of drug expenses paid by insurance companies, and thus pushed this cargo to patients and consumers,” he said.
Americans fight to meet health care costs, as already. One of the three Americans say they could not take the medication determined due to value and 11 percent of Americans They fail to meet their healthcare expenses, and Spanish could not meet with 18 percent of the adults.
Congress Budget Administration appreciates that 7.7 percent of Americans have not been insured, ie, medical expenses are out of pocket. For insured, for public health professionals, Trump believes that the insurance premiums will increase by progress with pharmaceutical tariffs.
“They will spread among anyone who pays for insurance as a whole. This is the concept of insurance,” Lee said.
More expensive drugs are produced in the state or Europe. They can also get the pricier. Currently, there are 10 percentage tariffs in the place that affects these drugs, but this can be higher than the current tariffs in the country with a break.
Drugs out of Europe are more often blockbuster drugs. For example, Eli Lilly’s weight loss medication is done in Ireland. If tariffs happen there, in Zepbound can work in the Zepbound to $ 1.086.37 for a monthly supply of non-pocket expenses for US patients.
Supply chain tension
In February, the American Hospital Association (AHA), in a letter that requires tariff exceptions, said the existing supply of pots will worsen the potential chain strains.
“Despite the ongoing efforts to build an internal supply chain, the United States has significantly contributed to international sources for both drugs and international sources for the device. The tariffs can reduce any reaction of these life-saving drugs and supplies in the United States,” he said. “US providers import antibiotics and unification antibiotics from many cancer and cardiovascular medicines, immunosupresives, antibiotics, antibiotics and China.
Aha al-Gazir rejected the request for additional comment.
“HeatrCare has a very perfect logistics chain and clearly varies from product to the product, but some are very complicated,” Numerof and Associates abras are very complicated.
For example, some APIs have passed two or three different processes and are all in the same place before they arrive in the United States to enter the last product.
“When you take all these relationships and threw them into the air and see how they wander, they are inevitably.”
In the United States, including more than 104 active drug deficiencies, including general antibiotics such as amoxicillin. China is one of the largest exporters in the world and the largest importer in the United States.
Another concern for its overprivilact trust in China is expected to increase by 7.8 percent in the next five years of the country’s API market. Market research firm modor intelligence.
Washington’s action call
When the CovID-19 pandemic was temporarily suspended, there were concerns that there were no enough medications in the strategic resource for a temporary suspension of the United States. As former President Joe Biden, Republicans, such as Arkansas Senator Tom cotton and Democrats, eventually called on to trust China for a pharmaceutical.
“When there are chains of supply chains or not only depending on special channels, this supply chain is fragile and there is a risk,” Lee said.
He called on the leadership to reduce antibiotic exports in the United States in the United States, including a prominent Chinese votes, including economist Liokui, including a trade war.
However, experts accept Trump’s rapid approach to companies and thus do not risk the patients.
Ahp, in the letter of February, the Tariffs said “Tariffs” should be selected in other stimuli to increase local production and to promote a stable supply chain.
“You can’t do this within 18 months, you want to do this, it’s good? Or, not even a four-year-old,” Abrams added.
Some companies said they said more pharmaceutical production. Swiss pharmacy giant Roche has announced a $ 50 billion investment in the United States in the next five years, which will enter funds to establish research and development facilities and expand existing production operations.
Roche is watching Novartis, which announces $ 23 billion in the next five years to expand the US infrastructure. It contains thousands of new jobs in seven facilities that will produce drugs and APIs.
According to Pous, the construction of such plants in production and the building will not resolve the issue immediately.
“It is important to note that the new pharmaceutical production capacity will take several years.
The White House did not meet Al Jazeera’s demand for comment.
